Synthesis of dihydrospiro furo[2,3-c]pyrazoles promoted by hypervalent iodine in water
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General
Melting points were measured by CINTEX programmable melting point apparatus and are uncorrected. 1 H and 13 C NMR spectra of samples in CDCl3 recorded on AVANCE-400 MHz and 500 MHz spectrometers. Chemical shifts (δ) are reported relative to TMS (δ = 0.0) as the internal standard. Mass spectra were recorded in ESI spectrometers. All high resolution mass spectra were recorded on QSTAR XL hybrid ms/ms system (Applied Bio systems/MDS sciex, foster city, USA), equipped with an ESI source (IICT, Hyderabad). TLC was performed on Merck 60 F-254 silica gel plates. The chemicals used in this work were obtained from commercial channels and were used without purification. Pyrazolone (1) (650 mg, 3.6 mmol) and benzaldehyde (2) (200 mg, 1.8 mmol) was suspended in water (10ml) in a two necked round bottomed flask fitted with a stopper, reflux condenser and the reaction mixture was heated to reflux while stirring. After disappearance of starting materials in 30 minutes as indicated by TLC, the heterogeneous reaction mass was allowed to come down to room temperature, added bis (acetoxy) iodobenzene (BAIB) (600 mg, 1.8 mmol) and continued stirring at room temperature. After addition, the reaction mass became homogenous and within 5 minutes, formation of desired product was observed as a solid (ascertained by TLC). Then, the separated solid was filtered, washed with water (3x 10ml) and the crude product was passed through flash column chromatography by eluting with 3-5% (ethyl acetate-hexane) to furnish the pure products. 3,3'-dimethyl-5'-oxo-1,1'-diphenyl-1,1', 3,3'-dimethyl-1,1'-diphenyl-4-(pyridin-3-yl)-1,4-dihydrospiro[furo[2,3-c 3,3'-dimethyl-4-(naphthalen-1-yl)-1,1'-diphenyl-1,4-dihydrospiro[furo[2,3-c 68 (m, 1H), 7.53-7.37 (m, 6H), 7.28-7.18 (m, 3H), 4.59 (s, 1H) , 2.57 (s, 3H), 2.08 (s, 3H) ppm; 13 C NMR (100 MHz, CDCl3): δ 167. 6, 165.4, 155.9, 155.2, 137.8, 137.7, 133.0, 132.8, 129.3, 128.9, 128.8,  128.4, 127.83, 127.8, 126.9, 126.69, 126.62, 125.5, 125.38, 125.35, 118.95, 118.91, 43.2, 20.2 3,3',4-trimethyl-1,1'-diphenyl-1,4-dihydrospiro[furo[2,3-c]pyrazole-5,4'-pyrazol]-5'(1'H)-one (4m) . C-NMR spectra's:

4-(3-methoxyphenyl)-3,3'-dimethyl-1,1'-diphenyl-1,4-dihydrospiro[furo[2,3-c]pyrazole-5,4'-pyrazol]-5'(1'H)-one (4c
4-(
3,3'-dimethyl-1,1'-diphenyl-4-(4-(trifluoromethyl)phenyl)-1,4-dihydrospiro[furo[2,3-c]pyrazole-5,4'-pyrazol]-5'(1'H)-one (4i
3,3'-dimethyl-1,1'-diphenyl-4-(4-(prop-2-yn-1-yloxy)phenyl)-1,4-dihydrospiro[furo[2,3-c]pyrazole-5,4'-pyrazol]-5'(1'H)-one (4k
1 H-NMR (500 MHz) spectrum of 4 in CDCl3. 13 C-NMR (125 MHz) spectrum of 4 in CDCl3.
1 H-NMR (500 MHz) spectrum of 4c in CDCl3. 13 C-NMR (125 MHz) spectrum of 4c in CDCl3.
1 H-NMR (500 MHz) spectrum of 4l in CDCl3. 13 C-NMR (125 MHz) spectrum of 4l in CDCl3.
